Search

The development of 5th generation mobile broadband systems, 5G to replace today's 4G, is in full swing. Chalmers is part of a two-year project that brings together industry and academia to develop a common global standard for future vehicle communication.

The University of Amsterdam (UvA)’s Faculty of Science, UvA Ventures Holding B.V. and Innovation Exchange Amsterdam (IXA-UvA) are pooling their resources to fund Macrobian Biotech BV, a single asset biotech company that will further develop medicine for the treatment of Parkinson’s disease.

On 9 September, Wilma van Ingen succeeded Herman Hazewinkel as chairperson of the University of Twente Funds foundation. Ms van Ingen is chairperson of the board of directors of the Nysingh Advocaten & Notarissen law firm with branches in Zwolle, Arnhem, Apeldoorn and Utrecht. She previously held the position of managing director at the chamber of commerce for the eastern Netherlands.

Budget Commissioner Günther Oettinger pleads with governments to reverse proposed €500M cut to next year’s Horizon 2020 budget next year saying, “If you are not prepared to invest in 2018, you will have to invest more in 2019 and 2020”

The Werner Siemens-Foundation has donated CHF 12 million to establish the Centre for Single-Atom Electronics and Photonics. ETH Zurich and the Karlsruhe Institute of Technology (KIT) are establishing the centre to develop new types of integrated circuits for communications networks

An assessment of the European Research Council’s outputs says 73 per cent represent breakthroughs or major advances

With its teaching licence revoked and the forced removal from its premises, the European University in St Petersburg is on life support. “We have lost virtually everything,” says one of its professors

Ex-MEP Vicky Ford joins UK Parliament science committee following storm over all-male line-up

Competition teams welcome audiences to hear their innovative solutions at an open seminar in Brussels on 26 September.

The centrepiece of Framework Programme 9 is to be ten moonshot projects that inspire the public and connect people to EU R&D. Researchers are starting to pitch in with their ideas

Clinical trials are fundamental to the development of new treatments for cancer, but annual accrual to studies worldwide is low, at an estimated at three to five percent.